These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 17932395)

  • 21. Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion.
    Urban T; Lim R; Merker VL; Muzikansky A; Harris GJ; Kassarjian A; Bredella MA; Plotkin SR
    Clin Nucl Med; 2014 May; 39(5):e301-7. PubMed ID: 24152623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours.
    Cardona S; Schwarzbach M; Hinz U; Dimitrakopoulou-Strauss A; Attigah N; Mechtersheimer section sign G; Lehnert T
    Eur J Surg Oncol; 2003 Aug; 29(6):536-41. PubMed ID: 12875862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
    Brenner W; Friedrich RE; Gawad KA; Hagel C; von Deimling A; de Wit M; Buchert R; Clausen M; Mautner VF
    Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):428-32. PubMed ID: 16404595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-Body Positron Emission Tomography with
    Fertitta L; Jannic A; Zehou O; Bergqvist C; Ferkal S; Moryousef S; Lerman L; Mulé S; Luciani A; Bapst B; Ezzedine K; Ortonne N; Itti E; Wolkenstein P
    J Invest Dermatol; 2024 Aug; 144(8):1754-1761.e1. PubMed ID: 38368929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].
    Bensaid B; Giammarile F; Mognetti T; Galoisy-Guibal L; Pinson S; Drouet A; Combemale P
    Ann Dermatol Venereol; 2007 Oct; 134(10 Pt 1):735-41. PubMed ID: 17978710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
    Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
    Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
    Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.
    Higham CS; Dombi E; Rogiers A; Bhaumik S; Pans S; Connor SEJ; Miettinen M; Sciot R; Tirabosco R; Brems H; Baldwin A; Legius E; Widemann BC; Ferner RE
    Neuro Oncol; 2018 May; 20(6):818-825. PubMed ID: 29409029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiological manifestations of abdominopelvic nerve tumours seen in neurofibromatosis type 1.
    Ozcan HN; Karcaaltincaba M; Oguz B; Haliloglu M
    Clin Radiol; 2014 Apr; 69(4):431-5. PubMed ID: 24361143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of
    Geitenbeek RTJ; Martin E; Graven LH; Broen MPG; Anten MHME; van der Pol JAJ; Verhoef C; Taal W
    J Neurooncol; 2022 Feb; 156(3):559-567. PubMed ID: 35025020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.
    Uthoff J; De Stefano FA; Panzer K; Darbro BW; Sato TS; Khanna R; Quelle DE; Meyerholz DK; Weimer J; Sieren JC
    J Neuroradiol; 2019 May; 46(3):179-185. PubMed ID: 29958847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
    Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
    J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant transformation in a sciatic plexiform neurofibroma in Neurofibromatosis Type 1 - imaging features that aid diagnosis.
    Chew DCY; Zhao DBH; Sittampalam K; Kumar SK
    J Radiol Case Rep; 2020 Dec; 14(12):1-13. PubMed ID: 33717399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of the diagnostic accuracy of 2-[
    Ko WS; Kim SJ
    Clin Radiol; 2024 Feb; 79(2):142-149. PubMed ID: 37968227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of PET in the assessment of patients with neurofibromatosis type 1.
    Bredella MA; Torriani M; Hornicek F; Ouellette HA; Plamer WE; Williams Z; Fischman AJ; Plotkin SR
    AJR Am J Roentgenol; 2007 Oct; 189(4):928-35. PubMed ID: 17885067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Ahlawat S; Blakeley JO; Rodriguez FJ; Fayad LM
    Neurology; 2019 Sep; 93(11):e1076-e1084. PubMed ID: 31395668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
    Attia S; Guirguis M; Le LQ; Chhabra A
    Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.
    Combemale P; Valeyrie-Allanore L; Giammarile F; Pinson S; Guillot B; Goulart DM; Wolkenstein P; Blay JY; Mognetti T
    PLoS One; 2014; 9(2):e85954. PubMed ID: 24516522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical plexiform neurofibroma in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin.
    Friedrich RE; Derlin T; Hagel C
    In Vivo; 2010; 24(6):871-6. PubMed ID: 21164047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.